Monash Ivf Group Ltd Net Assets

Latest as of June 2026: AU$253.47 Million AUD ≈ $179.35 Million USD

Monash Ivf Group Ltd net assets. Based on the latest financial reports, Monash Ivf Group Ltd (MVF) has net assets worth AU$253.47 Million AUD (≈ $179.35 Million USD) as of June 2026. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (AU$512.35 Million ≈ $362.52 Million USD) and total liabilities (AU$258.88 Million ≈ $183.18 Million USD). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. See MVF net asset quality score to measure how much of total assets are equity-financed.

Key Net Assets Metrics

Metric	Value
Current Net Assets	AU$253.47 Million
% of Total Assets	49.47%
Annual Growth Rate	N/A
5-Year Change	-6.09%
10-Year Change	55.01%
Growth Volatility	12.94

Net Assets of Monash Ivf Group Ltd (2013–2026)

Net assets of Monash Ivf Group Ltd from 2013 to 2026. This chart illustrates how Monash Ivf Group Ltd's net assets have evolved over time, based on quarterly financial data. Also explore how fast is Monash Ivf Group Ltd growing its equity to track the company's year-over-year net asset growth rate.

Annual Net Assets for Monash Ivf Group Ltd (2013–2026)

The table below shows the annual net assets of Monash Ivf Group Ltd from 2013 to 2026. For live market cap and overall valuation, see market cap of Monash Ivf Group Ltd.

Year	Net Assets	Change
2026-06-30	AU$253.47 Million ≈ $179.35 Million	+1.22%
2025-06-30	AU$250.42 Million ≈ $177.19 Million	+1.52%
2024-06-30	AU$246.66 Million ≈ $174.53 Million	-10.33%
2023-06-30	AU$275.07 Million ≈ $194.63 Million	+1.92%
2022-06-30	AU$269.89 Million ≈ $190.97 Million	+0.54%
2021-06-30	AU$268.44 Million ≈ $189.94 Million	+6.47%
2020-06-30	AU$252.12 Million ≈ $178.39 Million	+45.37%
2019-06-30	AU$173.43 Million ≈ $122.72 Million	+3.94%
2018-06-30	AU$166.86 Million ≈ $118.06 Million	+2.04%
2017-06-30	AU$163.52 Million ≈ $115.70 Million	+5.58%
2016-06-30	AU$154.88 Million ≈ $109.58 Million	+7.53%
2015-06-30	AU$144.03 Million ≈ $101.91 Million	+15.39%
2014-06-30	AU$124.82 Million ≈ $88.32 Million	+366.03%
2013-06-30	AU$-46.92 Million ≈ $-33.20 Million	--

Equity Component Analysis

This analysis shows how different components contribute to Monash Ivf Group Ltd's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.

Equity Composition Insights

Retained earnings have decreased by 9963900000.0% over the analyzed period, potentially due to dividend distributions or operating losses.

Monash Ivf Group Ltd Net Assets Breakdown (June 2026)

Monash Ivf Group Ltd net assets breakdown by equity component as of June 2026.

Component	Amount	Percentage
Common Stock	AU$506.79 Million	203.40%
Other Comprehensive Income	AU$-94.89 Million	-38.09%
Total Equity	AU$249.16 Million	100.00%

Monash Ivf Group Ltd Competitors by Market Cap

The table below lists competitors of Monash Ivf Group Ltd ranked by their market capitalization.

Company	Market Cap
M+S HIDRAVLIK AD BW 1 F:8Q3	$197.17 Million
Eurocash S.A. WAR:EUR	$197.24 Million
Cabio Biotech Wuhan Co Ltd SHG:688089	$197.28 Million
Meridian3 Industrials Acquisition Corp Class A Ordinary Shares NASDAQ:MIAC	$197.43 Million
Polytronics Technology Corp TW:6224	$197.08 Million
Matba Rofex SA BA:MTR	$197.01 Million
Willow Lane Acquisition Corp. Class A Ordinary Shares NASDAQ:WLAC	$196.98 Million
Honda India Power Products Limited NSE:HONDAPOWER	$196.98 Million

Equity Growth Attribution

This analysis shows how different factors contributed to changes in Monash Ivf Group Ltd's equity between the two most recent reporting periods.

Equity Growth Insights

From 2025 to 2026, total equity changed from 246,275,000 to 249,157,000, a change of 2,882,000 (1.2%).
Net income of 7,425,000 contributed positively to equity growth.
Dividend payments of 4,676,000 reduced retained earnings.
Other comprehensive income increased equity by 48,476,000.
Other factors decreased equity by 48,343,000.

Equity Change Factors (2025 to 2026)

Factor	Impact	Contribution
Net Income	AU$7.42 Million	+2.98%
Dividends Paid	AU$4.68 Million	-1.88%
Other Comprehensive Income	AU$48.48 Million	+19.46%
Other Changes	AU$-48.34 Million	-19.4%
Total Change	AU$-	1.17%

Book Value vs Market Value Analysis

This analysis compares Monash Ivf Group Ltd's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.

Valuation Insights

Current price-to-book ratio: 1.12x
The company is trading above its book value, indicating the market recognizes value beyond its reported assets.

Historical Price-to-Book Ratios

Date	Book Value per Share	Market Price	P/B Ratio
2013-06-30	AU$-0.28	AU$0.72	x
2014-06-30	AU$0.38	AU$0.72	x
2015-06-30	AU$0.62	AU$0.72	x
2016-06-30	AU$0.47	AU$0.72	x
2017-06-30	AU$0.69	AU$0.72	x
2018-06-30	AU$0.71	AU$0.72	x
2019-06-30	AU$0.69	AU$0.72	x
2020-06-30	AU$0.77	AU$0.72	x
2021-06-30	AU$0.68	AU$0.72	x
2022-06-30	AU$0.68	AU$0.72	x
2023-06-30	AU$0.70	AU$0.72	x
2024-06-30	AU$0.62	AU$0.72	x
2025-06-30	AU$0.63	AU$0.72	x
2026-06-30	AU$0.64	AU$0.72	x

Capital Efficiency Dashboard

This dashboard shows how efficiently Monash Ivf Group Ltd utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.

Capital Efficiency Insights

Current Return on Equity (ROE): 2.98%
The company may be facing challenges in efficiently utilizing shareholder equity.
DuPont Analysis Breakdown:
• Net Profit Margin: 2.76%
• Asset Turnover: 0.53x
• Equity Multiplier: 2.06x
Recent ROE (2.98%) is below the historical average (8.38%), suggesting potential challenges in capital efficiency.

Historical Capital Efficiency Metrics

Year	Return on Equity	Net Profit Margin	Asset Turnover	Equity Multiplier	Economic Value Added
2013	0.00%	-15.38%	0.36x	0.00x	AU$-13.48 Million
2014	2.07%	2.26%	0.46x	1.97x	AU$-9.90 Million
2015	14.84%	17.10%	0.44x	1.97x	AU$6.97 Million
2016	18.58%	18.38%	0.54x	1.86x	AU$13.29 Million
2017	18.11%	19.09%	0.54x	1.76x	AU$13.27 Million
2018	12.82%	14.18%	0.52x	1.74x	AU$4.69 Million
2019	11.46%	13.06%	0.52x	1.67x	AU$2.53 Million
2020	4.69%	8.06%	0.41x	1.42x	AU$-13.25 Million
2021	9.45%	13.70%	0.52x	1.34x	AU$-1.47 Million
2022	6.87%	9.57%	0.50x	1.44x	AU$-8.39 Million
2023	7.99%	10.22%	0.51x	1.54x	AU$-5.48 Million
2024	-2.70%	-2.56%	0.50x	2.10x	AU$-30.72 Million
2025	10.15%	9.20%	0.55x	2.00x	AU$380.50K
2026	2.98%	2.76%	0.53x	2.06x	AU$-17.49 Million

Industry Comparison

This section compares Monash Ivf Group Ltd's net assets metrics with peer companies in the Diagnostics & Research industry.

Industry Context

Industry: Diagnostics & Research
Average net assets among peers: $203,717,805
Average return on equity (ROE) among peers: -36.65%

Peer Company Comparison

Company	Net Assets	Return on Equity	Debt-to-Equity	Market Cap
Monash Ivf Group Ltd (MVF)	AU$253.47 Million	0.00%	1.02x	$197.12 Million
Australian Clinical Labs Ltd (ACL)	$5.46 Million	-165.12%	20.81x	$360.33 Million
Bcal Diagnostics Ltd (BDX)	$-826.19K	0.00%	0.00x	$19.57 Million
Cryosite Ltd (CTE)	$3.04 Million	-31.26%	0.45x	$41.44 Million
Genetic Signatures Ltd (GSS)	$16.18 Million	-10.68%	0.02x	$13.66 Million
Genetic Technologies Ltd (GTG)	$27.28 Million	-15.86%	0.11x	$4.01 Million
Healius Ltd (HLS)	$1.87 Billion	-27.65%	0.67x	$223.50 Million
Imagion Biosystems Ltd (IBX)	$-3.79 Million	0.00%	0.00x	$1.74 Million
Integral Diagnostics Ltd (IDX)	$93.42 Million	16.14%	1.09x	$551.49 Million
Inoviq Ltd (IIQ)	$19.62 Million	-45.72%	0.10x	$13.45 Million
Microba Life Sciences Ltd (MAP)	$7.70 Million	-86.33%	0.40x	$15.94 Million

About Monash Ivf Group Ltd

AU:MVF Australia Diagnostics & Research

Market Cap

$197.12 Million

AU$278.59 Million AUD

Market Cap Rank

#16456 Global

#446 in Australia

Share Price

AU$0.72

Change (1 day)

-2.05%

52-Week Range

AU$0.59 - AU$0.88

All Time High

AU$1.65